Beyond Comorbidity: Integrating AF and Heart Failure Management - Powered by Medtronic-Beyond Comorbidity: Integrating AF and Heart Failure Management

Beyond Comorbidity: Integrating AF and Heart Failure Management - Powered by Medtronic

Video Transcription

Video Summary

The panel discussed the growing overlap between atrial fibrillation (AF) and heart failure, especially HFpEF, noting rising mortality and the need for shared management. They reviewed the bidirectional relationship: heart failure promotes AF through elevated filling pressures and remodeling, while AF worsens heart failure via loss of synchrony and output.<br /><br />A major theme was early detection and screening. Speakers supported using both medical devices and consumer wearables, with continuous monitoring seen as increasingly important. Europe, China, and the U.S. were compared in how they deploy monitoring and coordinate AF-heart failure care. The group emphasized phenotype-based treatment, since tachycardia-mediated cardiomyopathy and HFpEF may require different strategies.<br /><br />Ablation was viewed as important not only for symptom relief, but potentially for reducing AF burden and improving outcomes, especially in heart failure patients. However, the panel agreed more randomized data are needed, particularly in HFpEF and mildly reduced EF. They also discussed AV node ablation with physiologic pacing as a useful option in selected, often frail patients.<br /><br />Looking ahead, the panel’s top priorities were continuous monitoring, better care pathways, stronger evidence, and improved integration of multidisciplinary management and biomarkers.

Keywords

atrial fibrillation

heart failure

HFpEF

continuous monitoring

wearables

catheter ablation

AV node ablation

multidisciplinary care